AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 459243.16 Face Value (Rs.) : 2 House : Vimal Agrawal
BSECurrent Price (Rs.) 3675.15Change (Rs.)59.15 (+1.64 %)
PREV CLOSE (Rs.) 3616.00
OPEN PRICE (Rs.) 3616.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7655
TODAY'S LOW / HIGH (Rs.)3612.50 3698.00
52 WK LOW / HIGH (Rs.)2335 3698
NSECurrent Price (Rs.) 3672.80Change (Rs.)58.2 (+1.61 %)
PREV CLOSE( Rs. ) 3614.60
OPEN PRICE (Rs.) 3620.90
BID PRICE (QTY) 3672.80 (8)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 95494
TODAY'S LOW / HIGH(Rs.) 3603.10 3700.60
52 WK LOW / HIGH (Rs.)2329.9 3700.6

Cash Flow

Select year
(Rs.in Million)
Particulars
Mar 2026
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Profit Before Tax
1377.65
1189.16
1113.93
745.25
909.48
Adjustment
163.46
112.11
83.03
131.30
91.75
Changes In working Capital
-652.93
178.93
-99.76
66.85
-200.39
Cash Flow after changes in Working Capital
888.18
1480.20
1097.20
943.40
800.84
Cash Flow from Operating Activities
529.19
1157.23
785.07
792.11
561.71
Cash Flow from Investing Activities
-428.92
-376.52
65.39
-559.60
-74.10
Cash Flow from Financing Activities
-167.92
-733.41
-1051.06
-108.20
-459.71
Net Cash Inflow / Outflow
-67.65
47.30
-200.60
124.31
27.90
Opening Cash & Cash Equivalents
175.12
129.49
329.83
206.36
177.51
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balalces frgn subsidiaries
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
107.47
176.79
129.23
330.67
205.41